Clinical Report: Sterile Water Injections for Pain Relief in Renal Colic

Overview

This meta-analysis evaluated the efficacy of sterile water injections (SWIs) for pain relief in renal colic compared to standard analgesics. Six randomized controlled trials were included, demonstrating that SWIs provide significant pain reduction with fewer side effects. The findings suggest SWIs as a promising alternative to NSAIDs and opioids, especially in patients contraindicated for these medications.

Background

Renal colic, caused by kidney and ureteric stones, affects approximately 12% of the global population and is characterized by severe pain and nausea. NSAIDs are the current first-line treatment due to their effectiveness and lower side effect profile compared to opioids, but they are contraindicated in patients with renal failure or gastrointestinal bleeding risk. Sterile water injections, initially used for labor-related back pain, have emerged as a potential analgesic option for renal colic due to similar pain mechanisms. However, evidence quality varies, and a systematic review was needed to assess SWI efficacy and safety compared to conventional analgesics.

Data Highlights

Key Findings

• Six randomized controlled trials met inclusion criteria, focusing on adults with imaging-confirmed urinary tract stones.
• SWIs demonstrated significant pain relief compared to placebo and some conventional analgesics.
• Time to onset of pain relief was rapid with SWIs, comparable to NSAIDs and opioids.
• SWIs were associated with fewer adverse effects, particularly avoiding nausea, vomiting, and drowsiness common with opioids.
• Heterogeneity among studies was moderate, with random-effects modeling applied for analysis.
• Quality assessment using Cochrane ROB2 tool indicated overall low to moderate risk of bias in included studies.

Clinical Implications

Sterile water injections represent a viable alternative for pain management in renal colic, particularly for patients contraindicated for NSAIDs or opioids. Their favorable side effect profile and rapid analgesic effect support consideration in clinical protocols. Further high-quality RCTs directly comparing SWIs to standard analgesics are warranted to solidify their role in practice.

Conclusion

SWIs provide effective and safe analgesia for renal colic, offering a promising alternative to conventional pain relief methods. Integration into clinical practice could improve patient outcomes, especially in populations at risk from NSAID or opioid side effects.

References

1. British Association of Urological Surgeons (BAUS) Guidelines 2024 -- Pain Management in Renal Colic
2. Cochrane ROB2 Tool 2019 -- Risk of Bias Assessment in Randomized Trials
3. Hozo et al. 2005 -- Estimating Mean and Variance from Median and Range
4. PROSPERO CRD42023474039 -- Systematic Review Protocol on SWI in Renal Colic